Since the last comprehensive review of anticoagulation in acute myocardial infarction four additional randomized control trials have been reported. The overwhelming majority of all trials favored anticoagulation. Rates of thromboembolism were higher in the control, and hemorrhagic complications in the anticoagulated group. Pooling of all randomized control trials gives mean case fatality rates of 19.6% for the control and 15.4% for the anticoagulated group, a relative reduction of 21% (P less than 0.05 or less than 0.001, depending on the analytic method). Five of six randomized control trials reported "no effect" because the difference favoring anticoagulation was not statistically significant. However, sample sizes in these "negative" papers were too small to protect against missing a 21% reduction in true case fatality rate due to anticoagulation (beta greater than 0.10). All patients who present no specific contraindication should receive anticoagulants during hospitalization for infarction.
This article has been cited by other articles:
O'Rourke, K.
(2007). An historical perspective on meta-analysis: dealing quantitatively with varying study results. JRSM
100: 579-582
[Full Text]
Conlin, A. E., Parnes, L. S.
(2007). Treatment of Sudden Sensorineural Hearing Loss: I. A Systematic Review. Arch Otolaryngol Head Neck Surg
133: 573-581
[Abstract][Full Text]
Cooper, C. J., Murphy, T. P.
(2007). The Case for Renal Artery Stenting for Treatment of Renal Artery Stenosis. Circulation
115: 263-270
[Full Text]
Aronow, W. S.
(2004). Management of the Elderly Person After Myocardial Infarction. J. Gerontol. A Biol. Sci. Med. Sci.
59: 1173-1185
[Abstract][Full Text]
Kincaid, E. H., Monroe, M. L., Saliba, D. L., Kon, N. D., Byerly, W. G., Reichert, M. G.
(2003). Effects of preoperative enoxaparin versus unfractionated heparin on bleeding indices in patients undergoing coronary artery bypass grafting. Ann. Thorac. Surg.
76: 124-128
[Abstract][Full Text]
Anand, S. S., Yusuf, S.
(2003). Oral anticoagulants in patients with coronary artery disease. J Am Coll Cardiol
41: 62S-69S
[Abstract][Full Text]
Chalmers, I., Hedges, L. V., Cooper, H.
(2002). A Brief History of Research Synthesis. Eval Health Prof
25: 12-37
[Abstract]
Ioannidis, J. P. A., Haidich, A.-B., Pappa, M., Pantazis, N., Kokori, S. I., Tektonidou, M. G., Contopoulos-Ioannidis, D. G., Lau, J.
(2001). Comparison of Evidence of Treatment Effects in Randomized and Nonrandomized Studies. JAMA
286: 821-830
[Abstract][Full Text]
Cairns, J. A., Theroux, P., Lewis, H. D. Jr., Ezekowitz, M., Meade, T. W.
(2001). Antithrombotic Agents in Coronary Artery Disease. Chest
119: 228S-252S
[Full Text]
Barton, S.
(2000). Which clinical studies provide the best evidence?. BMJ
321: 255-256
[Full Text]
Altman, R., Rouvier, J., Scazziota, A.
(2000). State-of-the-Art Review : Secondary Prevention of Myocardial Infarction: Beneficial Effect of Combining Oral Anticoagulant Plus Aspirin: Therapy Based on Evidence. CLIN APPL THROMB HEMOST
6: 126-134
Benson, K., Hartz, A. J.
(2000). A Comparison of Observational Studies and Randomized, Controlled Trials. NEJM
342: 1878-1886
[Abstract][Full Text]
Adetugbo, K., Williams, H.
(2000). How Well Are Randomized Controlled Trials Reported in the Dermatology Literature?. Arch Dermatol
136: 381-385
[Abstract][Full Text]
Anand, S. S., Yusuf, S.
(1999). Oral Anticoagulant Therapy in Patients With Coronary Artery Disease: A Meta-analysis. JAMA
282: 2058-2067
[Abstract][Full Text]
Knoll, G. A, Bell, R. C
(1999). Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials. BMJ
318: 1104-1107
[Abstract][Full Text]
Kunz, R., Oxman, A. D
(1998). The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials. BMJ
317: 1185-1190
[Abstract][Full Text]
Bath, F. J., Owen, V. E., Bath, P. M. W.
(1998). Quality of Full and Final Publications Reporting Acute Stroke Trials : A Systematic Review. Stroke
29: 2203-2210
[Abstract][Full Text]
Altman, R.
(1998). Controversies in Antithrombotic Therapy in Cardiovascular Diseases. CLIN APPL THROMB HEMOST
4: 11-24
[Abstract]
Naylor, C D.
(1997). Meta-analysis and the meta-epidemiology of clinical research. BMJ
315: 617-619
[Full Text]
Collins, R., MacMahon, S., Flather, M., Baigent, C., Remvig, L., Mortensen, S., Appleby, P., Godwin, J., Yusuf, S., Peto, R.
(1996). Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials. BMJ
313: 652-659
[Abstract][Full Text]
Oakley, A., Fullerton, D., Holland, J., Arnold, S., France-Dawson, M., Kelley, P., McGrellis, S.
(1995). Sexual health education interventions for young people: a methodological review. BMJ
310: 158-162
[Abstract][Full Text]
Harvard, T. C., Lau, J.
(1993). Meta-analytic stimulus for changes in clinical trials. Stat Methods Med Res
2: 161-172
[Abstract]
Hirsh, J., Cairns, J. A.
(1987). Analytic Reviews : Antithrombotic Tberapy in Acute Myocardial Infarction and Unstable Angina. J Intensive Care Med
2: 299-312
De Mey, C., Wellens, D., Vanhoutte, P. M.
(1979). Physiopathology and Pharmacotherapy of Occlusive Arterial Disorders. ANGIOLOGY
30: 433-439
Previous
